Last Updated: July 01, 2024
pharmalundensis.se has 4 NS records, 1 A records, 0 AAAA records, 1 MX records, and 1 TXT records. Name servers for pharmalundensis.se are b.ns14.net, a.ns14.net, c.ns14.net, d.ns14.net. A records for pharmalundensis.se are 34.105.211.218. MX records that process @pharmalundensis.se email are server.skogvall.com. We have observed pharmalundensis.se to have 1 subdomains. A subdomain count of 1 is considered a small digital footprint. The domain's primary website is hosted on a nginx web server at 34.105.211.218 in United Kingdom. The website's description is: "välkommen till pharmalundensis ab! pharmalundensis ab utvecklar läkemedel mot sjukdomar orsakade av tungmetallerna kvicksilver, bly och kadmium. vi bedömer att en rad sjukdomar, såsom kol och kronisk bronkit, fibromyalgi och kroniskt trötthetssyndrom orsakas av dessa metaller. vi har utvecklat en ny, effektiv och mild behandling (phal-501) för att binda upp och utsöndra dessa tungmetaller från […]" As of July 01, 2024, pharmalundensis.se does not have any threat intelligence reports of concern.
Search DigitalStakeout ASI to find another asset.
34.105.211.218
No DNS AAAA records
server.skogvall.com
b.ns14.net
a.ns14.net
c.ns14.net
d.ns14.net
pharmalundensis.se. 86400 IN TXT "v=spf1 a:mta.skogvall.com include:spf.mailjet.com a:mx1.skogvall.com a:mx2.skogvall.com include:turbo-smtp.com -all"
pharmalundensis.se has 1 subdomains in our inventory.
nginx
United Kingdom
og:locale: sv_se
og:type: website
og:title: - pharmalundensis
og:description: välkommen till pharmalundensis ab! pharmalundensis ab utvecklar läkemedel mot sjukdomar orsakade av tungmetallerna kvicksilver, bly och kadmium. vi bedömer att en rad sjukdomar, såsom kol och kronisk bronkit, fibromyalgi och kroniskt trötthetssyndrom orsakas av dessa metaller. vi har utvecklat en ny, effektiv och mild behandling (phal-501) för att binda upp och utsöndra dessa tungmetaller från […]
og:url: https://pharmalundensis.se/
og:site_name: pharmalundensis
article:modified_time: 2024-04-20t16:31:11+00:00
{"data":{"cert_index":897335931,"cert_link":"https:\/\/ct.googleapis.com\/logs\/eu1\/xenon2024\/ct\/v1\/get-entries?start=897335931&end=897335931","leaf_cert":{"all_domains":["pharmalundensis.se"],"extensions":{"authorityInfoAccess":"CA Issuers - URI:http:\/\/r3.i.lencr.org\/\nOCSP - URI:http:\/\/r3.o.lencr.org\n","authorityKeyIdentifier":"keyid:14:2E:B3:17:B7:58:56:CB:AE:50:09:40:E6:1F:AF:9D:8B:14:C2:C6\n","basicConstraints":"CA:FALSE","certificatePolicies":"Policy: 2.23.140.1.2.1","ctlPoisonByte":true,"extendedKeyUsage":"TLS Web server authentication, TLS Web client authentication","keyUsage":"Digital Signature, Key Encipherment","subjectAltName":"DNS:pharmalundensis.se","subjectKeyIdentifier":"2F:DD:D6:39:B8:2A:F9:00:46:21:B9:50:F1:22:E0:E2:A7:00:61:E6"},"fingerprint":"A0:EC:CB:BF:81:8F:42:40:87:26:21:93:45:D5:49:50:61:4E:71:DE","issuer":{"C":"US","CN":"R3","L":null,"O":"Let's Encrypt","OU":null,"ST":null,"aggregated":"\/C=US\/CN=R3\/O=Let's Encrypt","emailAddress":null},"not_after":1712913787,"not_before":1705137788,"serial_number":"320D679D92E21C6F3FAE2274F4BE588D16C","signature_algorithm":"sha256, rsa","subject":{"C":null,"CN":"pharmalundensis.se","L":null,"O":null,"OU":null,"ST":null,"aggregated":"\/CN=pharmalundensis.se","emailAddress":null}},"seen":1705141622.202593,"source":{"name":"Google 'Xenon2024' log","url":"https:\/\/ct.googleapis.com\/logs\/eu1\/xenon2024\/"},"update_type":"PrecertLogEntry"},"message_type":"certificate_update"}